v. 20 – Q4 2021
|Market Executive Summary||The Therapeutic Goods Administration (TGA) issued requirements to improve the accuracy of medicine dispensing via labelling changes, which include the addition of a mandatory machine readable GS1 Barcode for prescription medicines. The documented objectives of Therapeutic Goods Order (TGO) No.91 and TGO No.92 are:
TGO No. 106 mandates the following of GS1 standards on the usage and application of 2D data matrix codes on prescription medicines that are / are not serialised.
Since 1 Sept. 2020, a machine-readable GS1 code (i.e. EAN13 and/or 2D data matrix code) is required to be applied to prescription medicines. If using EAN13, it is encouraged to also apply a 2D data matrix code to encode the GTIN-14 in additional to LOT, EXP and SN.
TGO performed an industry consultation on TGO No. 106 which resulted in extending the requirement from 1 July 2021 to 1 January 2023.